CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | BLICKENSTAFF KIM D Director | Purchase | +172,189 | $2.90 | $500K | 172,189 |
| 2024-05-24 | WELCH DANIEL G Director | Option exercise | +293,203 | $1.74 | $510K | 293,203 |
| 2024-05-24 | WELCH DANIEL G Director | Option exercise | +366,744 | $1.64 | $601K | 659,947 |
| 2024-05-24 | WELCH DANIEL G Director | Option exercise · Stock Option (Right to Buy) | −293,203 | 19,547 | ||
| 2024-05-24 | WELCH DANIEL G Director | Option exercise · Stock Option (Right to Buy) | −366,744 | 0 | ||
| 2024-04-09 | Cui Xiangmin Director | Grant or award | +314,106 | 314,106 | ||
| 2024-04-09 | Cui Xiangmin Director | Grant or award | +1,675,236 | 1,675,236 | ||
| 2024-04-09 | Cui Xiangmin Director | Grant or award | +4,183,002 | 4,183,002 | ||
| 2024-04-09 | Sjogren Colleen Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-04-09 | Sjogren Colleen Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2024-04-09 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award | +1,378,989 | 1,378,989 | ||
| 2024-04-09 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award | +550,758 | 550,758 | ||
| 2024-04-09 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Stock Option (Right to Buy) | +486,669 | 486,669 | ||
| 2024-04-09 | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. | Grant or award · Stock Option (Right to Buy) | +388,299 | 388,299 | ||
| 2024-02-29 | Wentworth Kerry CHIEF REGULATORY OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-02-29 | Markel Stacy CHIEF PEOPLE OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-02-29 | Makunje Moses SEE REMARKS | Grant or award · Class A Common Stock | +250,000 | 250,000 | ||
| 2024-02-29 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-02-29 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-02-29 | Liu Dongfang CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 |
Page 8 of 15 · 291 trades